Increasing evidence indicates that an increase in the Wnt signaling pathway in a bone micro-environment can prevent the occurrence of myeloma, inhibiting the growth of myeloma in the bone by antagonizing DKK1 and DKK3 (89, 90). Here, DKK3 is linked to plasma cell myeloma.